Neuropeptide Y Receptor Type 4 (NPY4R) Antibody

Este producto es parte de NPY - Neuropeptide Y Receptor
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Neuropeptide Y Receptor Type 4 (NPY4R) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx304945
tested applications
ELISA, IHC

Description

NPY4R Antibody is a Rabbit Polyclonal against NPY4R.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Neuropeptide Y Receptor Type 4 (NPY4R)
Host
Rabbit
Reactivity
Human
Recommended Dilution
IHC: 1/20 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA, IHC
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P50391
Gene ID
100996758, 105379861, 5540
Alias
NPY4R,NPY4-R,PP1,PPYR1,Y4,PP1,neuropeptide Y receptor type 4,pancreatic polypeptide receptor 1
Background
Antibody anti-NPY4R
Status
RUO

Descripción

NPY4R, also known as the pancreatic polypeptide receptor, is a G protein-coupled receptor activated primarily by pancreatic polypeptide (PP) and, to a lesser extent, by peptide YY (PYY) and neuropeptide Y (NPY). NPY4R is expressed in the hypothalamus, brainstem, and peripheral tissues, particularly in the gastrointestinal tract, pancreas, and adipose tissue. Activation of NPY4R regulates appetite, energy balance, and gastrointestinal function. It couples to Gi/o proteins, inhibiting adenylate cyclase, reducing cAMP levels, and modulating neurotransmission. NPY4R plays a role in reducing food intake and regulating satiety, particularly following meal ingestion. Dysregulation of NPY4R is associated with obesity, metabolic disorders, and impaired pancreatic function. NPY4R agonists are being explored as therapeutic agents for obesity and type 2 diabetes, as enhancing NPY4R signaling can reduce appetite and improve glucose homeostasis. Its role in energy balance and metabolism highlights NPY4R as a promising target for managing obesity and metabolic diseases.

Related Products

FNab06742

NPY4R antibody

Ver Producto
abx005705

Neuropeptide Y Receptor Type 4 (NPY4R) Antibody

NPY4R Antibody is a Rabbit Polyclonal Antibody against NPY4R.

Ver Producto
abx210685

Neuropeptide Y receptor type 4 (NPY4R) Antibody

NPY4R Antibody is a Rabbit Polyclonal against NPY4R.

Ver Producto